Wegovy vs Zepbound: Which One Should You Start?
This question shows up every day.
People want the perfect choice.
Most people need a different mindset.
Pick one. Start. Learn your pattern. Adjust.
What they are
Wegovy is same as Ozempic and Zepbound is same as Mounjaro
Ozempic and Mounjaro are FDA-approved for type 2 diabetes, while Wegovy and Zepbound are FDA-approved for chronic weight management; the active medicine is the same within each pair, but the labeled indication and dosing schedule may differ.
Wegovy uses semaglutide.
Zepbound uses tirzepatide.
Semaglutide works on GLP-1 receptors.
Tirzepatide works on GLP-1 plus GIP receptors.
What matters more than the name
- Tolerance
- Consistency
- Time
- Tracking
Side effects and tolerance
Both medications cause similar GI side effects in many people.
Some people tolerate one better than the other.
In my clinic, I often see tirzepatide tolerated well.
That is an office pattern, not a rule for everyone.
If you have diabetes
Glucose control changes the timeline.
Many people see sugar improvements before major scale changes.
If you use insulin or meds that cause lows, coordination matters.
Do not adjust blindly.
The best plan for most people
Start one medication.
Expect little early.
Let your body settle on a dose.
Then decide based on trends.
When switching makes sense
- Side effects stay disruptive even after holding a dose
- Appetite control fades and the plan stalls
- Insurance coverage forces a change
Key takeaway
There is no perfect first choice.
There is a perfect next step.
Start the shot.
Track the trend.
Adjust with data.
How My Daily Health Journal helps
Log dose day, symptoms, and weight trend.
Track blood pressure and blood sugar if you monitor them.
Bring that pattern to your next visit.
That is how good decisions happen.
This post is for education. Discuss medication choice and switching with your prescribing clinician.